Valuation: Alkem Laboratories Limited

Market Cap 695B 7.28B 6.33B 5.88B 5.42B 10.21B 10.39B 69.56B 27.24B 345B 27.36B 26.76B 1,162B P/E 2026
27.5x
P/E 2027 * 29.8x
Enterprise Value 667B 6.99B 6.07B 5.64B 5.2B 9.79B 9.97B 66.75B 26.13B 331B 26.25B 25.67B 1,115B EV / Sales 2026
4.3x
EV / Sales 2027 * 4.07x
Free-Float
37.56%
Yield 2026
1%
Yield 2027 * 0.88%
1 day+2.54%
1 week+4.15%
Current month+4.43%
1 month+7.38%
3 months+8.84%
6 months+1.81%
Current year+5.63%
1 week 5,561.5
Extreme 5561.5
5,882.5
1 month 5,487
Extreme 5487
5,882.5
Current year 5,075
Extreme 5075
5,933.5
1 year 4,738.5
Extreme 4738.5
5,933.5
3 years 3,447
Extreme 3447
6,439.9
5 years 2,828
Extreme 2828
6,439.9
10 years 1,455
Extreme 1455
6,439.9
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 2024-01-31
Director TitleAgeSince
Director/Board Member 44 2013-08-08
Director/Board Member 63 2008-02-10
Director/Board Member 44 2019-11-10
Change 5-day change 1-year change 3-year change Capi.($)
+2.54%+4.15%+14.71%+45.57% 7.08B
-4.55%-2.61%+51.95%+151.91% 1,079B
-3.66%-1.33%+52.95%+46.62% 640B
-2.24%+0.19%+35.97%+70.64% 465B
-2.29%+1.12%+36.13%+31.18% 353B
-2.28%-0.69%+33.42%+40.48% 301B
-3.15%+0.25%+10.63%+15.03% 271B
-2.12%+3.31%+1.82%-37.38% 228B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 165B
Average -1.39%+4.51%+28.06%+49.89% 371.68B
Weighted average by Cap. -1.61%+4.86%+38.00%+72.84%

Financials

2026 2027 *
Net sales 146B 1.53B 1.33B 1.24B 1.14B 2.15B 2.19B 14.63B 5.73B 72.63B 5.75B 5.63B 244B 165B 1.73B 1.5B 1.4B 1.29B 2.43B 2.47B 16.54B 6.48B 82.13B 6.5B 6.36B 276B
Net income 25.13B 263M 229M 212M 196M 369M 375M 2.51B 984M 12.48B 988M 967M 41.97B 23.59B 247M 215M 199M 184M 346M 352M 2.36B 924M 11.72B 928M 908M 39.4B
Net Debt -28.13B -295M -256M -238M -219M -413M -420M -2.81B -1.1B -13.97B -1.11B -1.08B -46.99B -21.73B -228M -198M -184M -169M -319M -325M -2.17B -851M -10.79B -855M -836M -36.3B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
18,785
Date Price Change Volume
26-07-30 ₹5,816.50 +2.54% 301,501
26-07-29 ₹5,672.50 +0.37% 57,547
26-07-28 ₹5,651.50 +0.69% 58,815
26-07-27 ₹5,613.00 -0.36% 112,113
26-07-24 ₹5,633.50 +0.56% 55,151
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,816.50INR
Average target price
5,964.80INR
Spread / Average Target
+2.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALKEM Stock